The research of vaccine of cancer of the stomach

Alleged tumour seedling, namely by the researcher first the cellular factor CDNA that malignant tumor cure requires preparation, its clone records virus carrier to safe changeover, pack recombining blemish changeover to record virus grain, in order to affects the vaccine of tumor cell. Classics of seedling of this kind of tumour after 60 cobaltic radiate, the sex that cause tumor disappears, and cellular immunity is withheld, still secrete cellular factor continuously inside proper time.

" of seedling of alleged " tumour, namely by the researcher first the cellular factor CDNA that malignant tumor cure requires preparation, its clone records virus carrier to safe changeover, pack recombining blemish changeover to record virus grain, in order to affects the vaccine of tumor cell. Classics of " of seedling of tumour of this kind of " after 60 cobaltic radiate, the sex that cause tumor disappears, and cellular immunity is withheld, still secrete cellular factor continuously inside proper time. The with great concentration such as Chen Shishu, Qian Guanxiang the " Bai Jiesu of preparation of 10 years of time - 2 gene project changes " of seedling of tumour of cell of cancer of the stomach, the biological product that can be used at clinical trial at was being approved to be by SDA in October 2000 a kind of new drug, agree to have 8 little sample book clinical trial. Patient of 8 terminal cancer passes " 2 of seedling of this " tumour lunar cure and a curative effect observation of the month, confirming the patient accepts " of " tumour seedling to treat is safe, can be able to bear or endure suffer, and the illness is stable.
In view of the favorable result that clinical trial obtains little sample book, supervisory management board of national medicines and chemical reagents will approve " of seedling of this " tumour to enter Ⅰ period, Ⅱ period on March 29 this year clinical research. Be in Ⅰ period is clinical in research, the researcher will determine the use dosage of " of " tumour seedling further; Be in Ⅱ period is clinical in research, people hospital will be visited in surgery of Shanghai Ruijin hospital, Zhejiang the recrudesce after surgery chooses 120 surgeries in all, move or cannot operation and the patient of terminal cancer of the stomach that lacks other to treat a method has treatment, in order to enlarge remedial example, observe its curative effect deep.